Literature DB >> 92750

The pathogenesis of osteoarthrosis.

R W Stephens, P Ghosh, T K Taylor.   

Abstract

Recent investigations on protease inhibitors in articular cartilage have provided new insights into the possible initial lesions of osteoarthrosis. A hypothesis has been formulated based upon an impaired ability of chondrocytes to synthesize protease inhibitors, which leads to loss of matrix integrity and vascular invasion from subchondral bone and the joint margins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92750     DOI: 10.1016/0306-9877(79)90041-0

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

Review 1.  Neovascularisation and its role in the osteoarthritic process.

Authors:  R A Brown; J B Weiss
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

Review 2.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

Review 3.  Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.

Authors:  F D Hart; E C Huskisson
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

4.  Biosynthesis of proteoglycan in vitro by cartilage from human osteochondrophytic spurs.

Authors:  C J Malemud; V M Goldberg; R W Moskowitz; L L Getzy; R S Papay; D P Norby
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

Review 5.  Managing osteoarthritis pain when your patient fails simple analgesics and NSAIDs and is not a candidate for surgery.

Authors:  Mary McHughes; Arthur G Lipman
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

6.  Osteochondral angiogenesis and increased protease inhibitor expression in OA.

Authors:  R E Fransès; D F McWilliams; P I Mapp; D A Walsh
Journal:  Osteoarthritis Cartilage       Date:  2009-12-21       Impact factor: 6.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.